ReviewCureus2026
Nipah Virus in Focus: A Comprehensive Review of the Pathogenesis, Epidemiological Patterns, Diagnostic Advances, and Future Public Health Strategies.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nipah virus (NiV) remains one of the most concerning emerging pathogens due to its repeated spillover events, high mortality, and the absence of licensed vaccines or treatments. Its recurrence demonstrates that the ecological factors facilitating such outbreaks, including those linked to bat hosts, are still present. These patterns highlight the continued need for a coordinated One Health approach that connects human, animal, and environmental health. This review has four aims: (1) to summarize current understanding of NiV biology and pathogenesis, (2) to describe the epidemiological trends that shape how outbreaks unfold, (3) to assess recent advances in diagnostics, and (4) to highlight emerging strategies for prevention and control. Our narrative synthesis shows that NiV's ability to infect both the respiratory and nervous systems, combined with strong immune‑evasion mechanisms, contributes to rapid deterioration in many patients. Epidemiological evidence from South and Southeast Asia consistently links outbreaks to bat reservoirs, occasional intermediate hosts, and increasingly recognized person‑to‑person transmission. In diagnostics, improvements in rapid molecular tests, point‑of‑care tools, and serological platforms have expanded the ability to detect cases quickly in field settings. Promising progress is also being made in surveillance systems, ecological risk assessment, and the development of antiviral agents and vaccine candidates. By synthesizing current scientific and public health insights, this review underscores the need for sustained multidisciplinary strategies to mitigate future NiV threats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.